期刊文献+

核糖核苷酸还原酶研究 被引量:7

Studies on Ribonucleotide Reductase and Its Inhibitors as Anticancer Drugs
下载PDF
导出
摘要 核糖核苷酸还原酶广泛存在于各种生物中,是生物体内唯一的催化4种核糖核苷酸还原、生成相应的脱氧核糖核苷酸的酶。该酶是DNA合成和修复的关键酶和限速酶,对细胞的增殖和分化起着调控作用。不同生物中的RR根据其结合的金属辅助因子不同而分类。虽然不同类型RR之间的氨基酸序列相似性很低,但它们有十分相似的三级结构的活性中心和相同的催化功能。RR分子中包含2个变构位点,即酶活性中心和底物特异结合位点。活性中心通过生物有机自由基的作用催化核糖核苷酸还原;底物特异结合位点通过变构作用调控4种dNTPs在细胞内的平衡。因此,该酶不仅是研究DNA合成与修复、细胞增殖与分化及癌症的治疗与抗癌药物开发的重要靶点,同时也是研究酶的结构与功能以及酶的催化机理等的重要工具。本文总结了该酶的种类与分布、结构特征、催化机理及作为抗癌药物开发靶点等方面的研究进展。 Ribonucleotide reductases (RR, EC 1.174.1) exist in all kinds of living ceils and are the only type of enzymes that can catalyze the reduction of four kinds of ribonucleotides to deoxyribonucleotides necessary for DNA replication and repairing, As one of the key enzymes for DNA synthesis, it controls cell proliferation and differentiation. RR can be grouped into three classes based on their structures and catalytic mechanisms. Although the similarities in amino acids are very few (〈10%)among different classes, the three classes of RR do have similar active sites and have the same catalytic functions. All RR has two kinds of functional allosteric sites, the catalytic sites and the substrate specificity sites. The catalytic active centers of the enzymes activate and reduce ribonucleotides through protein free radicals. The substrate specificity site controls cellular balances of four dNTPs through its allosteric regulation. RR is not only an important target in the studies of DNA replication, cell proliferation or differentiation, and development of anticancer drugs, but also an important model for the elucidation of structure-function relationship and catalytic mechanisms of organic radical enzymes. This paper reviews recent advances of its distribution, structure, function and its inhibitors as anticancer substances.
出处 《科技导报》 CAS CSCD 2008年第8期79-83,共5页 Science & Technology Review
基金 广东省科技攻关项目(2006B20101005)
关键词 核糖核苷酸还原酶 结构 功能 抑制剂 抗癌药物 ribonucleotide reductase structure function inhibitor anticancer drugs
  • 相关文献

参考文献27

  • 1Reichard P. From RNA to DNA, why so many ribonucleotide reductases [J]. Science, 1993, 260: 1773-1777.
  • 2Jordan A, Reichard P. Ribonucleotide reductases [J]. Ann Rev Biochem, 1998, 67: 71-98.
  • 3Kolberg M, Strand K R, Graft P, et al. Structure, function and mechanism of ribonucleotide reductases [J]. Biochim Biophys Acta, 2004, 1699: 1- 34.
  • 4Stubbe J, Donk J W A. Protein radicals in enzyme catalysis [J]. Chem Rev, 1998, 98: 705-762.
  • 5马华智,吴纯启,廖明阳.羟基脲的非临床分子毒理学研究进展[J].癌变.畸变.突变,2004,16(5):318-320. 被引量:5
  • 6Lozano G, Elledge S J. p53 sends nucleotides to repair DNA [J]. Nature, 2000, 404: 24-25.
  • 7Lawrence C C, Stubbe J. The function of adenosylcobalamin in the mechanism of ribonucleoside triphosphate reductase from Lactobacillus leichmannii [J]. Curr Opin Chem Biol, 1995, 2: 650-655.
  • 8Eklund H, Fontecave M. Glycyl radical enzymes: a conservative structural basis for radicals [J]. Structure, 1999, 7: R257-R262.
  • 9Frey P A, Booker S J. Radical mechanisms of S-adenosylmethioninedependent enzymes [J]. Adv Protein Chem, 2001, 58: 1-45.
  • 10Knappe J, Wagner A F. Stable glycyl radical from pyruvate formatelyase and ribonucleotide reductase [J]. Adv Protein Chem, 2001, 58: 277-315.

二级参考文献47

  • 1[1]PAR Pharmaceuticals.Hydroxyurea capsules,USP.2002.[DB/OL]www.parpharm.com/downloads/hydroxyurea-po.pdf
  • 2[2]Ferguson RP,Arun A,Carter C,et al. Hydroxyurea treatment of sickle cell anemia in hospital-based practices[J].Am J Hematol,2002, 70:326- 328.
  • 3[3]Lisziewicz J,Foli A,Lori WM. Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns[J].Drug Sa,2003, 26(9): 605- 624.
  • 4[4]Yarbro JW. Mechanism of action of hydroxyurea[J]. Semin Oncol,1992,19(9): 1- 10.
  • 5[5]Mayhew CN,Phillips JD,Greenberg RN,et al. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitorswith potential anti-HIV-1 activity[J]. Stem Cells, 1999 , 17(6):345- 356.
  • 6[6]Oakley OR,Hughes NK,Phillips JD,et al. The effects of lithium in reversing hydroxyurea induced suppression of hematopoietic progenitor cells in vitro using retroviral infected long-term marrow cultures[J]. Rom J Physiol,1998, 35(1- 2): 67- 78.
  • 7[7]Navarra P,Del CarmineR,Ciabattoni G,et al. Hydroxyurea:relationship between toxicity and centrally induced adrenal activation[J].Pharmacol Toxicol, 1990, 67(3): 209- 215.
  • 8[8]Wiger R,Hongslo JK,Evenson DP,et al. Effects of acetaminophen and hydroxyurea on spermatogenesis and sperm chromatin structure in laboratory mice[J]. Reprod Toxicol, 1995,9(1): 21- 33.
  • 9[9]Shin JH,Mori C,Shoita K. Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment[J]. Toxicol Appl Pharmacol,1999,155(2): 139- 149.
  • 10[10]Evenson DP, Jost LK. Hydroxyurea exposure alters mouse testicular kinetics and sperm chromatin structure[J]. Cell Prolif,1993, 26(2): 147- 159.

共引文献4

同被引文献88

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部